Oric Pharmaceuticals
Price & Volume
Stats
See more52W Range | $7.23-$14.68 |
Market Cap | $1.2B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.32 |
News
See moreYahoo Finance • 2 months ago
ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02
Yahoo Finance • 3 months ago
ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
Yahoo Finance • 5 months ago
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance • 5 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC
About
CEO | Dr. Jacob M. Chacko M.B.A., M.D. |
Address | 240 E. Grand Ave, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 111 |